Rasilez HCT

Rasilez HCT is a medication used to treat high blood pressure in adults. It is indicated for patients whose blood pressure is not adequately controlled on aliskiren or hydrochlorothiazide used alone. Rasilez HCT is also recommended as a replacement therapy for patients who are already taking aliskiren and hydrochlorothiazide at the same dose levels.

This medication works by acting on the renin-angiotensin system, which helps to lower blood pressure. It is not suitable for initial therapy and should be used under close medical supervision, especially in patients with severe renal impairment. Common side effects include mild and transient issues such as diarrhea.

Rasilez HCT is a combination of aliskiren, an angiotensin receptor blocker, and hydrochlorothiazide, a diuretic. It is important to monitor renal function and blood pressure regularly while taking this medication. If symptoms of hypotension occur, the patient should be placed in the supine position and given an intravenous infusion of normal saline if necessary.

Overall, Rasilez HCT is a treatment option for patients with mild to moderate essential hypertension who require combination therapy. It should be used with caution in patients with mild to moderate renal impairment and under close medical supervision to avoid potential side effects like hypotension and renal dysfunction.